MoneyWorks4Me

Biofil Chem & Pharma - Quaterly Results

12 Aug 2025 Evaluate
Net sales declined -23.81%  to  Rs. 64.33 million from Rs. 84.43 millions.The company almost doubled its revenue to Rs. 24.11 millions  from Rs. 1.69 millions in the quarter ended June 2025.Operating profit surged to 28.38 millions from the corresponding previous quarter of 3.38 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 64.33 84.43 -23.81 64.33 84.43 -23.81 334.02 400.35 -16.57
Other Income 28.32 0.29 9665.52 28.32 0.29 9665.52 3.05 4.90 -37.76
PBIDT 28.38 3.38 739.64 28.38 3.38 739.64 11.52 13.07 -11.86
Interest 0.09 0.11 -18.18 0.09 0.11 -18.18 0.37 0.42 -11.90
PBDT 28.29 3.27 765.14 28.29 3.27 765.14 11.15 12.65 -11.86
Depreciation 0.66 0.99 -33.33 0.66 0.99 -33.33 3.80 3.99 -4.76
PBT 27.63 2.28 1111.84 27.63 2.28 1111.84 7.35 8.66 -15.13
TAX 3.52 0.59 496.61 3.52 0.59 496.61 1.78 1.56 14.10
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.32 -0.84 -61.90
PAT 24.11 1.69 1326.63 24.11 1.69 1326.63 5.57 7.10 -21.55
Equity 162.74 162.74 0.00 162.74 162.74 0.00 162.74 162.74 0.00
PBIDTM(%) 44.12 4.00 1002.00 44.12 4.00 1002.00 3.45 3.26 5.65
Peers